Skip to main content
Clinical Trials/NCT02571699
NCT02571699
Unknown
Not Applicable

Minimum Effective Volume of Lidocaine-Bupivacaine for Ultrasound-Guided Subgluteal Sciatic Nerve Block

McGill University Health Centre/Research Institute of the McGill University Health Centre1 site in 1 country60 target enrollmentMarch 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Injuries to the Ankle and Foot
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Enrollment
60
Locations
1
Primary Endpoint
success rate
Last Updated
9 years ago

Overview

Brief Summary

The aim of this study is to determine the minimum effective volume of LA in 90 % of patients (MEV90) required for US-guided subgluteal sciatic nerve block.

Detailed Description

The aim of this study is to determine the minimum effective volume of LA in 90 % of patients (MEV90) required for US-guided subgluteal sciatic nerve block. Success rate is defined as a minimal composite score of 6 points (out of 8 points) at 30 minutes.

Registry
clinicaltrials.gov
Start Date
March 2016
End Date
December 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Responsible Party
Principal Investigator
Principal Investigator

De Tran

Associate Professor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Eligibility Criteria

Inclusion Criteria

  • age between 18 and 75 years
  • American Society of Anesthesiologists classification 1-3
  • body mass index between 20 and 35

Exclusion Criteria

  • adults who are unable to give their own consent
  • pre-existing neuropathy (assessed by history and physical examination)
  • coagulopathy (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. platelets≤ 100, International Normalized Ratio≥ 1.4 or partial prothrombin time ≥ 50)
  • renal failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. creatinine ≥ 100)
  • hepatic failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. transaminases ≥ 100)
  • allergy to LA
  • pregnancy
  • prior surgery in the subgluteal region
  • chronic pain syndromes requiring opioid intake at home

Outcomes

Primary Outcomes

success rate

Time Frame: 0-30 minutes

minimal composite score of 6 out of 8 points

Study Sites (1)

Loading locations...

Similar Trials